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Somatic mutations in mitochondrial DNA (mtDNA) have been detected in hepatocellular carcinoma (HCC). However, it remains
unclear whether mtDNA copy number and mitochondrial biogenesis are altered in HCC. In this study, we found that mtDNA copy
number and the content of mitochondrial respiratory proteins were reduced in HCCs as compared with the corresponding non-
tumorous livers. MtDNA copy number was significantly reduced in female HCC but not in male HCC. Expression of the peroxisome
proliferator-activated receptor g coactivator-1 was significantly repressed in HCCs (Po0.005), while the expression of the
mitochondrial single-strand DNA-binding protein was upregulated, indicating that the regulation of mitochondria biogenesis is
disturbed in HCC. Moreover, 22% of HCCs carried a somatic mutation in the mtDNA D-loop region. The non-tumorous liver of the
HCC patients with a long-term alcohol-drinking history contained reduced mtDNA copy number (Po0.05) and higher level of the
4977bp-deleted mtDNA (Po0.05) as compared with non-alcohol patients. Our results suggest that reduced mtDNA copy number,
impaired mitochondrial biogenesis and somatic mutations in mtDNA are important events during carcinogenesis of HCC, and the
differential alterations in mtDNA of male and female HCC may contribute to the differences in the clinical manifestation between
female and male HCC patients.
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Hepatocellular carcinoma (HCC) is one of the most common
cancers in Taiwan. The incidence of HCC in males is 3–6 times
higher than that in females. Lower tumour recurrence rate and
better 5-year survival after resection of HCC were found for female
patients as compared to males (Nagasue et al, 1989; Jwo et al,
1992). However, the molecular mechanism underlying these
observations is not clear.
Recently, somatic mutations in the mitochondrial DNA
(mtDNA) have been identified in various human cancers such
as colon cancer, gastric cancer and HCC (Polyak et al, 1998;
Fliss et al, 2000; Nishikawa et al, 2001; Sanchez-Cespedes et al,
2001). Human mtDNA is a 16.5-kb circular double-stranded
DNA molecule, which contains genes coding for 13 polypeptides
involved in respiration and oxidative phosphorylation, two
rRNAs and a set of 22 tRNAs that are essential for protein
synthesis in mitochondria (Anderson et al, 1981). There are 2–10
copies of mtDNA in each mitochondrion, with up to several
thousand mitochondria per human cell. Moreover, nuclear DNA
provides all of the gene products necessary for mtDNA replica-
tion and transcription, as well as other components of the
oxidative phosphorylation system (Scarpulla, 1997). These
nuclear DNA products include the mitochondrial single-stranded
DNA-binding protein (mtSSB), mitochondrial transcription
factor A (mtTFA), nuclear respiratory factor-1 (NRF-1) and
peroxisome proliferator-activated receptor g coactivator-1
(PGC-1). However, alterations in the mtDNA content and in the
factors involved in the stimulation of the mtDNA replication and
transcription within HCC and the corresponding non-tumorous
liver remain obscure.
To evaluate any alteration in the quality or quantity of mtDNA
within HCC and the corresponding non-tumorous liver between
female and male patients, we determined the copy number and
mutations of mtDNA in the tumour tissues and in the
corresponding non-tumorous liver tissues from both male and
female HCC patients. Alterations in gene expression of the nuclear
DNA-encoded factors involved in the regulation of mtDNA
replication and transcription were also analysed.
MATERIALS AND METHODS
Human HCC tissues
Histologically confirmed HCC and corresponding non-tumorous
liver tissues were obtained from 18 patients, including nine males
and nine females. All the tissues were kept in liquid nitrogen
immediately after surgical resection at the Taipei Veterans General
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sHospital, according to a protocol approved by the committee for
conducting human research at the hospital.
Determination of MtDNA copy number
Total DNA was extracted from tissues using the TRIzol Reagent
(Life Technologies) according to the instructions of the manu-
facturer. The mtDNA copy number was determined using a
competitive polymerase chain reaction (PCR) method (Lee et al,
1998, 2004). In brief, a known amount of the internal DNA
standard was introduced with the DNA sample into the PCR
reaction mixture. The PCR reactions were carried out for 25
cycles in a 50ml reaction mixture containing 200ng DNA, 200mM of
each dNTP and 40pmol of each primer (BA1, L495, ND1L and
ND1H) (Table 1), 1.0U of Taq DNA polymerase, 50mM KCl,
1.5mM MgCl2,1 0 m M Tris–HCl (pH 9.0), 0.1% Triton X-100
and 0.01% (wv
 1) gelatin. The intensities of the PCR products
of the target and internal standard DNAs were analysed. The
intensity ratio of the DNA bands was used to calculate the mtDNA
copy number.
Quantitative real-time reverse transcription (RT)–PCR
analysis
Total RNA was extracted from tissues using the TRIzol Reagent
(Life Technologies), according to the instructions of the manu-
facturer. The first-strand cDNA was synthesised with a random
primer pd(N)6 in a 33ml mixture using RT–beads (Amersham
Pharmacia Biotech). Real-time quantitative PCR was performed
using the ABI PRISM 7700 (PE Applied Biosystems) and
results were analysed with the accompanying software. The
primers for b-actin, PGC-1, NRF-1, mtTFA and mtSSB are
listed in Table 1. The DNA-intercalating SyBr green reagent was
used for detection of the RT–PCR product. The PCR cycle used
was as follows: 501C (2min), 951C (10min), followed by 40
cycles of 951C (15s), 601C (1min). The alteration in gene
expression was obtained using the DDCt method in which all
samples are first normalised to the level of b-actin in each sample.
Relative normalised units were then compared between the tumour
tissue and the non-tumorous liver tissue obtained from the
same HCC patient.
Immunoblot analysis
Total protein concentrations of tissue lysates were determined with
the Bradford reagent (Bio-Rad). In all, 10mg of each lysate were
subjected to SDS–PAGE/immunoblot analysis using mouse
monoclonal antibodies specific for the 72kDa subunit of the
succinate-ubiquinol oxidoreductase (complex II, A-11142, Mole-
cular Probes) and the core 2 subunit of the ubiquinol-cytochrome
c oxidoreductase (complex III, A-11143, Molecular Probes),
respectively, and the secondary horseradish peroxidase-conjugated
sheep-anti-mouse antibody (Amersham Biosciences) and an
enhanced chemiluminescence detection method (ECL Western
Blotting System, Amersham Biosciences).
Direct sequencing analysis of MtDNA D-loop region
The primers L16190 and H602 were used for the amplification of a
982bp DNA fragment from the D-loop region of mtDNA. All PCR
products were purified and sequenced directly with the Ampli-
Cycle sequencing kit (Perkin-Elmer) according to the instructions
of the manufacturer. Both strands of the sequence were,
respectively, analysed by using the primers L16190 and H602,
and the primer L76 was used for confirming the alteration in the
poly C tract.
Detection and quantification of the 4977bp-deleted
MtDNA
Using a previously described PCR method (Lee et al, 2001), the
primers L8150 and H13650 were used for the amplification of a
524bp PCR product from the 4977bp-deleted mtDNA. The
primers L3304 and H3836 were used for the amplification of a
533bp DNA fragment from total mtDNA. The proportion of the
4977bp-deleted mtDNA was determined by the ratio of the highest
dilution fold that allowed the 524bp PCR product amplified from
the 4977bp-deleted mtDNA to be visible on the gel to that which
allowed the 533bp PCR product to be visibly amplified from the
total mtDNA under identical conditions.
Statistical analysis
Data are presented as mean7s.e.m. except where indicated.
Comparisons among multiple groups were made by an analysis
of Student’s t-test. Stepwise multiple regression analysis was
adopted to identify the variable with statistical significance. The
Scientific Package for Social Sciences (SPSS), version 10.0, software
for Windows was used. A value of Po0.05 was considered
statistically significant.
RESULTS
Alteration in mtDNA copy number of HCC
To evaluate whether any changes in the abundance of mtDNA
occurred within the tumour tissues of HCC patients, we analysed
the mtDNA copy number of the tumour tissues and the
corresponding non-tumorous liver tissues by a competitive PCR
technique. We found a direct correlation between the copy number
of mtDNA from the tumour and the corresponding non-tumorous
liver tissues of these HCC patients (r¼0.753, Po0.0005,
Figure 1A). However, the mean copy number of mtDNA in the
non-tumorous tissues of the male HCC patients (53087484) was
significantly lower than that of the female patients (80277969)
(Po0.05, Figure 1B). Moreover, the mean copy number of mtDNA
in the tumour tissues (62627614) of the female HCC patients was
significantly lower than that of the corresponding non-tumorous
liver tissues (Po0.05), though no significant difference in the
mtDNA copy number was found between the tumour and the
Table 1 Sequences of the oligonucleotide primers used in this study
Target gene
Primer
name Sequences (50–30)
b-actin BA1 CATGTGCAAGGCCGGCTTCG
L495 CTGGGTCATCTTCTCGCGGT
MtDNA (ND1) ND1L TCTCACCATCGCTCTTCTAC
ND1H TTGGTCTCTGCTAGTGTGGA
MtDNA (D-loop) L16190 CCCCATGCTTACAAGCAAGT
L76 CACGCGATAGCATTGCGAGACGCTG
H602 GCTTTGAGGAGGTAAGCTAC
MtDNA (Deletion) L8150 CCGGGGGTATACTACGGTCA
H13650 GGGGAAGCGAGGTTGACCTG
MtDNA (ND1) L3304 AACATACCCATGGCCAACCT
H3836 GGCAGG AGTAATCAGAGGTG
b-actin BAF TGGCATTGCCGACAGGAT
BAR GCTCAGGAGGAGCAATGATCT
mtSSB mtSSBF CCTCAGAGACGTGGCATATCAA
mtSSBR CGCCTCACATTATTTTTATCCATGT
NRF-1 NRF-1F TTGGAGAATGTGGTGCGTAAGT
NRF-1R GAGAGGCGGCAGTTCTGAGT
mtTFA mtTFAF CCAAAAAGACCTCGTTCAGCTTA
mtTFAR CTTTACAGTCTTCAGCTTTTCCTGC
PGC-1 PGC-1F CCAAATGACCCCAAGGGTTC
PGC-1R TATGAGGAGGAGTGGTGGGTG
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patients (Figure 1B).
Respiratory protein contents were reduced in HCC
Immunoblot analyses indicated that the cellular content of the
nuclear-encoded mitochondrial respiratory proteins, the 72kDa
subunit of the succinate-ubiquinol oxidoreductase (complex II)
and the core 2 subunit of the ubiquinol-cytochrome c oxido-
reductase (complex III) were significantly reduced in HCCs
(Po0.005 and Po0.004, respectively) when compared with the
corresponding non-tumorous livers (Figure 2A). Further analyses
revealed that decreased expression of the mitochondrial respira-
tory proteins in tumour tissues was found in both male and female
HCC patients as compared with those in the corresponding non-
tumorous livers (Figure 2B). The concomitant reduction in the
copy number of mtDNA and the content of mitochondrial
respiratory proteins (Figures 1 and 2) strongly suggests that the
biogenesis of mitochondria was repressed in human HCC.
MtSSB expression was not correlated with mtDNA content
in HCC
Mitochondria rely upon nuclear genes to regulate their biogenesis
and maintenance of mtDNA. Using a real-time quantitative
RT–PCR method, we found that the expression of mtSSB
mRNA correlated directly with the copy number of mtDNA
in the non-tumorous tissues of the female HCC patients
(r¼0.883, Po0.005) and the male HCC patients (r¼0.816,
Po0.05), respectively (Figure 3A). In contrast, no correlation
was found in the expression of mtSSB mRNA and the abundance
of mtDNA in either the male or female HCC tumour tissues
(Figure 3B).
PGC-1 expression was repressed in HCC
Further analysis showed that the average mRNA expression of
mtSSB was significantly upregulated in the tumour tissues of the
male HCC patients as compared with that in the corresponding
non-tumorous tissues (Po0.05), but the average mRNA levels of
mtSSB were only slightly increased in the tumour tissues of the
female HCC patients (Figure 4A). Moreover, analyses of the mRNA
expressions of the NRF-1 and mtTFA genes in the tumour and the
corresponding non-tumorous liver tissues of the HCC patients
showed that no significant difference was observed (Figure 4B
and C). In contrast, a significant reduction in the mRNA level
of the PGC-1 of the tumour tissues was observed in 61% (11 out
of 18) of the HCC patients, including six females and five males
(Figure 5A and B).
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Figure 1 MtDNA copy number in HCC. Panel A shows a positive
correlation between the copy number of mtDNA within the tumour
tissues and the corresponding non-tumorous tissues (r¼0.753;
Po0.0005). Panel B shows the mean copy number of mtDNA within
the tumour tissues and the corresponding non-tumorous tissues from the
female and male HCC patients. The results are presented as mean7s.e.m.
Comparisons between the group means were analysed by Student’s t-test.
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Figure 2 Mitochondrial respiratory proteins in HCC. Panel A shows the
relative content of the mitochondrial respiratory proteins, the 72kDa
subunit of the succinate-ubiquinol oxidoreductase (complex II) and the
core 2 subunit of the ubiquinol-cytochrome c oxidoreductase (complex III),
determined by immunoblot analysis described in Materials and methods.
Panel B shows the histogram of the protein content (expressed as arbitrary
units, a.u.) of each mitochondrial respiratory protein in non-tumorous and
tumour tissues from five female and six male HCC patients. The results are
presented as mean7s.e.m. * represents a significant decrease in the
protein content of the tumour tissues as compared with that of the
corresponding non-tumorous tissues (Po0.05, Student’s t-test).
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To analyse the qualitative alteration of mtDNA in the tumour
tissues of HCC patients, we used a direct sequencing method to
determine the somatic mutation and sequence variation in the D-
loop region (from nucleotide position (np) 16190 to np 602) of
mtDNA in the tumour and corresponding non-tumorous liver
tissues of the HCC patients. We detected a somatic deletion of a
cytidine in a poly C tract starting at np 303 in 22% (four out of 18)
of HCC tumour tissues. Microsatellite DNA alterations in the D-
loop region were found in 11% (one out of nine) of tumour tissues
of the female patients and in 33% (three out of nine) of tumour
tissues of the males. All the nucleotide changes detected in the
present study were homoplasmic.
Alteration in accumulation of mtDNA 4977bp deletion
in HCC
We further observed that the common 4977bp deletion occurred
and accumulated in the tumour tissues and in the corresponding
non-tumorous liver tissues of HCC patients. In the 36 liver samples
examined, the 4977bp-deleted mtDNA was detected in all of the
tumours and the non-tumorous liver tissues of the HCC patients
(Figure 6A). Interestingly, the mean proportion of the 4977bp-
deleted mtDNA in the non-tumorous tissues of the male HCC
patients (0.010470.0016%) was significantly higher than that of
the female patients (0.006070.0011%) (Po0.05, Figure 6B).
Moreover, the mean proportion of the 4977bp-deleted
mtDNA was significantly decreased in the tumour tissues
(0.003570.0008%) as compared with that in the corresponding
non-tumorous liver tissues (0.010470.0016%) of the male HCC
patients (Po0.005), but the phenomenon was not significant in the
female HCC patients (Figure 6B).
In the present study, 39% (seven out of 18) of the HCC patients
have a history of long-term drinking of alcohol. Analyses of the
relation of alcohol consumption with the level of mtDNA copy
number and the accumulation of the mtDNA with the 4977bp
deletion revealed that the mean copy number of mtDNA in the
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Figure 3 Correlation between the expression of mtSSB mRNA and
mtDNA copy number. Panel A shows a positive correlation between the
expression of mtSSB mRNA and the copy number of mtDNA within the
non-tumorous tissues of the female HCC patients (the closed symbols,
r¼0.883; Po0.005) and of the male HCC patients (the open symbols,
r¼0.816; Po0.05), respectively. Panel B shows a loss of the relationship
between the expression of mtSSB mRNA and the copy number of mtDNA
within the tumour tissues of the female HCC patients (the closed symbols,
r¼0.201; P¼0.604) and of the male HCC patients (the open symbols,
r¼0.029; P¼0.946), respectively.
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Figure 4 Alterations in the mRNA expressions of mtSSB, mtTFA and
NRF-1 in HCC. Alterations in the mRNA expressions of mtSSB (panel A),
mtTFA (panel B) and NRF-1 (panel C) were analysed by the DDCt
method, as described in Materials and methods. Data are first normalised to
the level of b-actin in each sample. The results are presented as
mean7s.e.m. Comparisons between the group means were analysed by
Student’s t-test. A value of Po0.05 was considered statistically significant.
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long-term drinking of alcohol (alcohol group, 54477632) was
significantly lower than that of 11 HCC patients without a history
of long-term drinking of alcohol (non-alcohol group, 74447904)
(Po0.05, Figure 7A). In contrast, the mean proportion of the
4977bp-deleted mtDNA in the non-tumorous tissues of the alcohol
group (0.010970.0021%) was significantly higher than that of the
non-alcohol group (0.006570.0010%) (Po0.05, Figure 7B).
DISCUSSION
Mitochondria are involved in multiple cellular processes such as
energy metabolism, apoptosis and generation of reactive oxygen
species (ROS). Alterations in oxidative phosphorylation of tumour
cells are proposed to play a causative role in tumour formation or
in the manifestation of clinical phenotype and malignant potential
of the tumour (Augenlicht and Heerdt, 2001). Our results
demonstrated for the first time that the copy number of mtDNA,
the content of mitochondrial respiratory proteins and mRNA
expression of PGC-1 are significantly decreased in HCC. It was
recently observed that there are differential expressions of
mitochondrial proteins in carcinomas (Cuezva et al, 2002); it is
possible that the expression of mitochondrial citrate synthase, a
standard usually used in mitochondrial disease studies, is changed
in the mitochondria of carcinomas. Consequently, we examined
the changes in the content of mitochondrial respiratory proteins in
relation to total cellular protein rather than to the citrate synthase.
We found that the cellular content of mitochondrial respiratory
complex II and complex III subunits was significantly reduced in
HCC as compared with the corresponding non-tumorous livers. In
addition, it has been demonstrated that PGC-1 is required for
mitochondrial biogenesis (Wu et al, 1999) and for the regulation of
hepatic gluconeogenesis (Yoon et al, 2001). These findings suggest
that mitochondrial biogenesis is impaired during liver carcinogen-
esis. Our results not only support the observation (Warburg, 1956)
that cancer cells have a respiratory deficiency, but also agree with
the observation of Cuezva et al (2002), who reported that the
expression level of the mitochondrial b-F1-ATPase and Hsp 60,
and the cellular content of mtDNA were reduced in HCCs.
In the analysis for nucleotide changes located in the D-loop
region of mtDNA, 1-bp deletion of a mononucleotide repeat (poly
C) tract at np 303–309 in the D-loop region of mtDNA was
detected in four out of 18 (22%) HCC patients. The poly C tract
was recently reported to harbour deletions or insertions at a very
high frequency in several primary tumours (Sanchez-Cespedes
et al, 2001). Moreover, this region was found to be highly
susceptible to oxidative damage as compared with the other
regions of mtDNA (Mambo et al, 2003). These results, together
with the observation that oxidative stress was high in HCC
(Toyokuni et al, 1995), suggest that oxidative damage may
contribute to the changes of the mononucleotide repeat at np
303–309 in the D-loop region of mtDNA in HCCs.
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Figure 5 Alteration in the mRNA expression of PGC-1 in HCC.
Alteration in the mRNA expression of PGC-1 was analysed by RT–PCR
method (panel A) and was quantified by the DDCt method (panel B)a s
described in Materials and methods. Data are first normalised to the level of
b-actin in each sample. The results are presented as mean7s.e.m. *
represents a significant alteration in the mRNA level of PGC-1 of the
tumour tissues as compared with that of the corresponding non-tumorous
tissues (Po0.05, Student’s t-test).
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Figure 6 MtDNA 4977bp deletion in HCC MtDNA with the 4977bp
deletion was detected by the PCR technique described in Materials and
methods. Using the primers L8150 and H13650, a 524bp PCR product
amplified from the 4977bp-deleted mtDNA in the tumour part (T) and in
the corresponding non-tumorous tissue (N) were separated on a 1.5%
agarose gel and detected under UV transillumination after ethidium
bromide staining. M: 100bp DNA ladder. The numbers above the gel lanes
indicate the patients (panel A). The mean proportions of the 4977bp-
deleted mtDNA in the tumour tissues were compared with the
corresponding non-tumour tissues (panel B). The results are presented
as mean7s.e.m. Comparisons between the group means were analysed by
Student’s t-test.
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mtSSB is strictly regulated and correlates directly with mtDNA
content (Schultz et al, 1998). Our results showed that the
expression of mtSSB correlated with the mtDNA copy number in
the non-tumorous tissue, but not in the tumour tissue of HCC
patients (Figure 3). In contrast, the expressions of mtTFA and its
upstream transcription factor NRF-1 were not significantly altered
in HCC (Figure 3). MtTFA is required for efficient heavy- and
light-strand transcription and also participates in the replication
and maintenance of mtDNA (Virbasius and Scarpulla, 1994). NRF-
1 has been demonstrated to be an important activator of
promoters for mtTFA and components of the mitochondrial
electron transport chain (Scarpulla, 1997). The findings indicate
that a loss in the strict regulation of the mtSSB expression may
contribute to a decreased copy number of mtDNA in HCC.
In this study, the proportion of mtDNA with the 4977bp
deletion was significantly reduced in the tumour tissues of the
male HCC patients as compared with the corresponding non-
tumorous tissues. Similarly, a slight decrease in the proportion of
deleted mtDNA was also observed in the tumour tissues of the
female HCC patients. Our results are in agreement with previous
findings in HCC (Kotake et al, 1999) and in human oral cancers
(Lee et al, 2001). Moreover, it was found that the proportion of
mtDNA with deletion in the more rapidly dividing tissues was
lower than that of tissues with a slow turnover rate (Kotake et al,
1999). Thus, the decrease in the proportion of mtDNA with
deletion in tumour tissues may have resulted from that the deleted
mtDNA molecules were diluted in the HCC cells after high mitotic
segregation.
Heavy alcohol consumption has been documented as one of
HCC’s risk factors (Chen et al, 1997). We found that the
HCC patients with a history of long-term drinking of alcohol
have a significantly decreased mtDNA copy number and an
obviously increased level of mtDNA deletion in their liver (Figure
7A and B). It has been demonstrated that acute or chronic
ethanol intoxication causes hepatic oxidative stress and mito-
chondrial dysfunction in human and experimental animals
(Cederbaum, 1999). Ethanol induced hepatic mtDNA depletion
after a single binge in mice (Demeilliers et al, 2002), or chronic
ethanol intoxication in aged rats (Cederbaum, 1999). Multiple
hepatic mtDNA deletions were frequently observed in the
liver tissue and white blood cells (WBC) obtained from patients
with alcoholic liver disease (ALD) (Mansouri et al, 1997).
Together, these results suggest that ethanol intoxication might
induce a decrease in the copy number of mtDNA and an increase
in the proportion of mtDNA deletion in the liver tissues of
male HCC patients.
Several studies have provided evidence that mtDNA plays an
important role in cellular sensitivity to cancer therapies (Singh
et al, 1999). It has been suggested that the mitochondrion could be
the integrator of many signals that have a potential impact on
tumour-related process. Our results suggest that alterations in the
mutations and copy number of mtDNA in the tumour tissues
might influence tumour formation, phenotype and the sensitivity
to chemotherapeutic agents.
In summary, our results demonstrated that reduced mtDNA
copy number, impaired mitochondrial biogenesis and somatic
mutations in mtDNA occurred concomitantly in HCC tissues.
Moreover, a decreased mtDNA content combined with somatic
mutations in the D-loop region of mtDNA of the non-tumorous
livers or HCC cells might contribute to the difference in the clinical
manifestation, progression and mortality rate between female and
male HCC patients.
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